InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.71%)
As of: Aug 21, 2026 · 3:59 PM EDT

InflaRx (IFRX) Raw Materials (2023 - 2025)

InflaRx (IFRX) posted Raw Materials of $92922.6 for Q2 2025, up 5.93% sequentially from $87717.8 in Q4 2024, and down 37.66% YoY from $149056.3 in Q2 2024.

InflaRx (IFRX) Raw Materials (2023 - 2025) Analysis & Trends

InflaRx has reported Raw Materials for 3 years, with the latest figure at $92922.6 in Q2 2025.

  • Quarterly Raw Materials fell 37.66% year-over-year to $92922.6 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $92922.6 (down 37.66% YoY) and the FY2024 annual result came in at $88845.9, down 80.61% from the prior year.
  • Raw Materials climbed to $92922.6 in Q2 2025 per IFRX's latest filing, from $87717.8 in the prior quarter.
  • Over five years, Raw Materials peaked at $1214.0 billion in Q3 2023 and troughed at $87717.8 in Q4 2024.
  • A 3-year average of $242.8 billion and a median of $149056.3 in 2024 frame the typical range for Raw Materials.
  • The sharpest annual moves came in 2024 and 2025: Raw Materials plunged 80.75% in 2024, then plunged 37.66% in 2025.
  • Over 3 years, Raw Materials stood at $455725.1 in 2023, then slumped by 80.75% to $87717.8 in 2024, then rose by 5.93% to $92922.6 in 2025.
  • According to Business Quant data, Raw Materials over the past three periods registered $92922.6, $87717.8, and $149056.3 for Q2 2025, Q4 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn

Historic Data

Download Data
DateValue
Jun 30, 2025 92,922.57
Dec 31, 2024 87,717.79
Jun 30, 2024 149,056.32
Dec 31, 2023 455,725.11
Sep 30, 2023 1,214.04 Bn